Hologic Inc. buy melinda
Start price
02.11.17
/
50%
€34.72
Target price
29.12.17
€40.59
Performance (%)
12.39%
End price
29.12.17
€39.02
Summary
This prediction ended on 29.12.17 with a price of €39.02. The prediction had a final performance of 12.39%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Hologic Inc. | -2.069% | -2.069% | -7.214% | 10.972% |
iShares Core DAX® | -1.670% | -1.001% | 10.864% | 12.563% |
iShares Nasdaq 100 | -4.184% | -1.145% | 37.458% | 41.078% |
iShares Nikkei 225® | -4.967% | -5.783% | 18.828% | 0.655% |
iShares S&P 500 | -2.834% | -0.572% | 25.875% | 39.960% |
According to melinda what are the pros and cons of Hologic Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Hologic Inc. diskutieren
Globale Tuberkulose Testmarkt.
Hologic ist die Nummer 1 weltweit in der Entwicklung, Herstellung und Vermarktung von Diagnosesystemen und medizinischer Bildgebung auf der Gesundheit von Frauen gewidmet. Der Anwendungsbereich der Gruppe ist wie folgt: - Mammographie (39,3%): Mammographie-Systeme, Detektoren ..
(Vom Mitglied beendet)
Stopped prediction by melinda for Hologic Inc.
Hologic Inc.
Start price
Target price
Perf. (%)
€49.93
07.06.21
07.06.21
€55.00
07.06.22
07.06.22
42.14%
08.06.22
08.06.22
Could be worthwhile Investment >10% per year
Hologic Inc.
Start price
Target price
Perf. (%)
€56.50
20.10.20
20.10.20
€60.00
04.11.21
04.11.21
-11.63%
07.06.21
07.06.21
Could be worthwhile Investment >10% per year
Hologic Inc.
Start price
Target price
Perf. (%)
€36.31
07.02.18
07.02.18
€39.24
30.07.18
30.07.18
7.30%
30.07.18
30.07.18
Could be worthwhile Investment >10% per year